Abstract
Purpose
This study was done to assess the prognostic value of computed tomography coronary angiography (CTCA) in a large multicentre population of patients with suspected coronary artery disease (CAD) and, in particular, its incremental value compared with traditional methods for risk stratification.
Materials and methods
This is a retrospective observational study that began in January 2003 conducted on patients with suspected CAD assessed with CTCA on the basis of symptoms (chest pain, dyspnoea) and/or abnormal or equivocal stress test and/or a high cardiovascular risk profile. The participating centres will provide data obtained with CTCA performed with 16-slice or higher equipment. Exclusion criteria are renal insufficiency, allergy to iodinated contrast material, pregnancy and previous myocardial infarction or revascularisation (percutaneous coronary intervention and/or coronary artery bypass graft). All patients are stratified by means of clinical assessment and/or data retrieved from a clinical database. Risk factors considered are hypertension, dyslipidaemia, diabetes mellitus, smoking, family history and obesity. Symptoms are classified as absent, typical chest pain, atypical chest pain and dyspnoea. Primary endpoints are death, major adverse cardiovascular events (cardiac death, unstable angina requiring hospitalisation, acute myocardial infarction) and shifting of cardiovascular risk category on the basis of coronary plaque burden. The secondary endpoint is coronary revascularisation. Telephone interviews and/or clinical databases are used for the follow-up. The study will be conducted on a population >1,000 patients.
Conclusions
The information collected from the Prognostic Registry for Coronary Artery Disease (PRORECAD) will provide insight into the prognostic value of CTCA in addition to demographic and clinical features. The results will allow for better use and interpretation of CTCA for prognostic purposes.
Riassunto
Obiettivo
Scopo del presente lavoro è stato valutare il valore prognostico della angiografia coronarica mediante tomografia computerizzata (CTCA) in una ampia popolazione multicentrica di pazienti con sospetta malattia coronarica (CAD) ed in particolare il valore incrementale rispetto ai tradizionali sistemi di stratificazione del rischio.
Materiali e metodi
Questo è uno studio osservazionale retrospettivo con inizio da gennaio 2003 su pazienti con sospetta CAD valutati mediante CTCA sulla base di sintomi (dolore toracico, dispnea) e/o per stress test alterato o dubbio e/o per un elevato profilo di rischio cardiovascolare. I centri partecipanti forniscono i dati ottenuti mediante CTCA con apparecchiatura a 16-strati o superiore. Criteri di esclusione sono: insufficienza renale, allergia al mezzo di contrasto iodato, gravidanza, pregresso infarto miocardico e rivascolarizzazione [rivascolarizzazione coronaria percutanea (PCI) e/o rivascolarizzazione chirurgica miocardica mediante confezionamento di bypass coronarici (CABG)]. Tutti i pazienti vengono stratificati mediante valutazione clinica e/o dati derivanti da database clinico. I fattori di rischio considerati sono: ipertensione, dislipidemia, diabete mellito, abitudine tabagica, familiarità, obesità. I sintomi vengono classificati come assenza di sintomi, dolore toracico tipico, dolore toracico atipico, dispnea. Gli obiettivi primari dello studio sono: morte; eventi cardiaci avversi maggiori (MACE) (vale a dire, morte cardiaca, ricovero per angina instabile, infarto miocardico acuto); variazione della categoria di prevalenza del rischio cardiovascolare sulla base del carico di placca coronarica. Gli obiettivi secondari sono: rivascolarizzazione coronarica. Per il follow-up viene utilizzato il contatto telefonico e/o il database clinico. Lo studio viene effettuato su una popolazione di riferimento di più di 1000 pazienti.
Conclusioni
Le informazioni raccolte dal Registro di Prognosi per la Malattia delle Arterie Coronarie (PRORECAD) aggiungeranno importanti informazioni sul valore prognostico della CTCA oltre alle caratteristiche demografiche e cliniche. I risultati consentiranno un utilizzo ed una interpretazione ottimale della CTCA ai fini prognostici.
Similar content being viewed by others
References/Bibliografia
Maffei E, Martini C, De Crescenzo S et al (2010) Low dose CT of the heart: a quantum leap into a new era of cardiovascular imaging. Radiol Med 115:1179–1207
Shaw LJ, Raggi P, Schisterman E et al (2003) Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 228:826–833
Schroeder S, Achenbach S, Bengel F et al (2008) Cardiac computed tomography: indications, applications, limitations, and training requirements: report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology. Eur Heart J 29:531–556
Taylor AJ, Cerqueira M, Hodgson JM et al (2010) ACCF/SCCT/ACR/ AHA/ASE/ASNC/NASCI/SCAI/ SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol 56:1864–1894
Agatston AS, Janowitz WR, Hildner FJ et al (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827–832
Nieman K, Cademartiri F, Lemos PA et al (2002) Reliable noninvasive coronary angiography with fast submillimeter multislice spiral computed tomography. Circulation 106:2051–2054
Nieman K, Oudkerk M, Rensig BJ et al (2001) Coronary angiography with multislice computed tomography. Lancet 357:599–603
Cademartiri F, Runza G, Belgrano M et al (2005) Introduction to coronary imaging with 64-slice computed tomography. Radiol Med 110:16–41
Cademartiri F (2009) Cardiac CT: the missing piece of the puzzle. Eur Radiol 19:2584–2585
Cademartiri F, La Grutta L, Palumbo A et al (2009) Computed tomography coronary angiography vs. stress ECG in patients with stable angina. Radiol Med 114:513–523
Cademartiri F, Luccichenti G, Marano R et al (2003) Non-invasive angiography of the coronary arteries with multislice computed tomography: state of the art and future prospects. Radiol Med 106:284–296
Cademartiri F, Luccichenti G, Marano R et al (2003) Spiral CT-angiography with one, four, and sixteen slice scanners. Technical note. Radiol Med 106:269–283
Cademartiri F, Luccichenti G, Marano R et al (2004) Use of saline chaser in the intravenous administration of contrast material in non-invasive coronary angiography with 16-row multislice Computed Tomography. Radiol Med 107:497–505
Cademartiri F, Maffei E, Palumbo A et al (2010) Coronary calcium score and computed tomography coronary angiography in high-risk asymptomatic subjects: assessment of diagnostic accuracy and prevalence of nonobstructive coronary artery disease. Eur Radiol 20:846–854
Cademartiri F, Malago R, Belgrano M et al (2007) Spectrum of collateral findings in multislice CT coronary angiography. Radiol Med 112:937–948
Cademartiri F, Marano R, Luccichenti G et al (2004) Normal anatomy of the vessels of the heart with 16-row multislice computed tomography. Radiol Med 107:11–21
Cademartiri F, Seitun S, Romano M et al (2008) Prognostic value of 64-slice coronary angiography in diabetes mellitus patients with known or suspected coronary artery disease compared with a nondiabetic population. Radiol Med 113:627–643
Aldrovandi A, Maffei E, Palumbo A et al (2009) Prognostic value of computed tomography coronary angiography in patients with suspected coronary artery disease: a 24-month follow-up study. Eur Radiol 19:1653–1660
Carrigan TP, Nair D, Schoenhagen P et al (2009) Prognostic utility of 64-slice computed tomography in patients with suspected but no documented coronary artery disease. Eur Heart J 30:362–371
Hadamitzky M, Freissmuth B, Meyer T et al (2009) Prognostic value of coronary computed tomographic angiography for prediction of cardiac events in patients with suspected coronary artery disease. JACC Cardiovasc Imaging 2:404–411
Maffei E, Seitun S, Martini C et al (2011) Prognostic value of CT coronary angiography: focus on obstructive vs. nonobstructive disease and on the presence of left main disease. Radiol Med 116:15–31
Pundziute G, Schuijf JD, Jukema JW et al (2007) Prognostic value of multislice computed tomography coronary angiography in patients with known or suspected coronary artery disease. J Am Coll Cardiol 49:62–70
Schuijf JD, Poldermans D, Shaw LJ et al (2006) Diagnostic and prognostic value of non-invasive imaging in known or suspected coronary artery disease. Eur J Nucl Med Mol Imaging 33:93–104
van Werkhoven JM, Schuijf JD, Gaemperli O et al (2009) Prognostic value of multislice computed tomography and gated single-photon emission computed tomography in patients with suspected coronary artery disease. J Am Coll Cardiol 53:623–632
Van Werkhoven JM, Cademartiri F, Seitun S et al (2010) Diabetes: prognostic value of CT coronary angiography—comparison with a nondiabetic population. Radiology 256:83–92
Min JK, Dunning A, Lin FY et al (2011) Rationale and design of the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter) Registry. J Cardiovasc Comput Tomogr 5:84–92
Min JK, Shaw LJ, Devereux RB et al (2007) Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol 50:1161–1170
Mollet NR, Cademartiri F, van Mieghem CA et al (2005) Highresolution spiral computed tomography coronary angiography in patients referred for diagnostic conventional coronary angiography. Circulation 112:2318–2323
Maffei E, Palumbo AA, Martini C et al (2009) “In-house” pharmacological management for computed tomography coronary angiography: heart rate reduction, timing and safety of different drugs used during patient preparation. Eur Radiol 19:2931–2940
Guaricci AI, Schuijf JD, Cademartiri F et al (2010) Incremental value and safety of oral ivabradine for heart rate reduction in computed tomography coronary angiography. Int J Cardiol 156:28–33
Cademartiri F (2006) Is calcium the key for the assessment of progression/ regression of coronary artery disease? Heart 92:1187–1188
Cademartiri F, Runza G, La Grutta L et al (2005) Non-invasive evaluation of coronary calcium. Radiol Med 110:506–522
Morise AP, Haddad WJ, Beckner D (1997) Development and validation of a clinical score to estimate the probability of coronary artery disease in men and women presenting with suspected coronary disease. Am J Med 102:350–356
Morise AP, Diamond GA (1995) Comparison of the sensitivity and specificity of exercise electrocardiography in biased and unbiased populations of men and women. Am Heart J 130:741–747
Mowatt G, Cummins E, Waugh N et al (2008) Systematic review of the clinical effectiveness and costeffectiveness of 64-slice or higher computed tomography angiography as an alternative to invasive coronary angiography in the investigation of coronary artery disease. Health Technol Assess 12:iii–iv, ix–143
Di Cesare E, Carbone I, Carriero A et al (2012) Clinical indications for cardiac computed tomography. From the Working Group of the Cardiac Radiology Section of the Italian Society of Medical Radiology (SIRM). Radiol Med 117(6):901–938
Bueno H, Armstrong PW, Buxton MJ et al (2011) The future of clinical trials in secondary prevention after acute coronary syndromes. Eur Heart J 13:1583–1589
Author information
Authors and Affiliations
Corresponding author
Additional information
Studio finanziato/sponsorizzato con fondi istituzionali di SIRM, Bando SIRM per la Ricerca per il biennio 2009–2010. Studio Patrocinato dalla Sezione di CardioRadiologia della SIRM. Studio registrato su ClinicalTrials.gov Identifier: NCT01384721.
Rights and permissions
About this article
Cite this article
Maffei, E., Midiri, M., Russo, V. et al. Rationale, design and methods of CTCA-PRORECAD (Computed Tomography Coronary Angiography Prognostic Registry for Coronary Artery Disease): a multicentre and multivendor registry. Radiol med 118, 591–607 (2013). https://doi.org/10.1007/s11547-012-0912-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-012-0912-9
Keywords
- Computed tomography coronary angiography
- Coronary artery disease
- Prevalence of disease
- Prognosis
- Risk stratification
- Registry